blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP4349857

EP4349857 - MONOBODY-BASED CHIMERIC ANTIGEN RECEPTOR AND IMMUNE CELL INCLUDING SAME [Right-click to bookmark this link]
StatusRequest for examination was made
Status updated on  08.03.2024
Database last updated on 02.09.2024
FormerThe international publication has been made
Status updated on  02.12.2022
Most recent event   Tooltip26.07.2024Change: Validation statespublished on 28.08.2024  [2024/35]
26.07.2024Change - extension statespublished on 28.08.2024  [2024/35]
Applicant(s)For all designated states
Vaxcell-Bio
12-55 Sandan-gil
Hwasun-eup
Hwasun-gun
Jeollanam-do 58141 / KR
[2024/15]
Inventor(s)01 / RHEE, Joon Haeng
Gwangju 61903 / KR
 [2024/15]
Representative(s)Marks & Clerk LLP
15 Fetter Lane
London EC4A 1BW / GB
[2024/15]
Application number, filing date22811624.024.05.2022
[2024/15]
WO2022KR07379
Priority number, dateKR2021006727625.05.2021         Original published format: KR 20210067276
[2024/15]
Filing languageKO
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2022250431
Date:01.12.2022
Language:KO
[2022/48]
Type: A1 Application with search report 
No.:EP4349857
Date:10.04.2024
Language:EN
[2024/15]
Search report(s)International search report - published on:KR01.12.2022
ClassificationIPC:C07K14/705, C07K16/28, C07K14/725, C12N5/0783, A61K35/17, C12N15/62, A61P35/00
[2024/15]
CPC:
A61K39/4611 (EP,KR,US); C07K14/7051 (EP,KR,US); A61K35/17 (US);
A61K39/0005 (KR); A61K39/4631 (EP,KR,US); A61K39/464422 (EP,KR,US);
A61P35/00 (EP,KR,US); C07K14/705 (EP); C07K14/70517 (KR);
C07K14/70521 (KR); C07K14/70575 (KR); C07K16/2866 (EP,US);
C12N15/62 (EP); C12N5/06 (EP); C12N5/0636 (EP);
A61K2239/13 (US); A61K2239/31 (EP,KR); A61K2239/38 (EP,KR);
A61K2239/54 (EP,KR); C07K2317/53 (US); C07K2317/622 (EP);
C07K2319/02 (KR,US); C07K2319/03 (EP,KR,US) (-)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2024/15]
TitleGerman:CHIMÄRER ANTIGENREZEPTOR AUF MONOKÖRPERBASIS UND IMMUNZELLE DAMIT[2024/15]
English:MONOBODY-BASED CHIMERIC ANTIGEN RECEPTOR AND IMMUNE CELL INCLUDING SAME[2024/15]
French:RÉCEPTEUR ANTIGÉNIQUE CHIMÉRIQUE À BASE DE MONOCORPS ET CELLULE IMMUNITAIRE LE COMPRENANT[2024/15]
Entry into regional phase24.11.2023Translation filed 
24.11.2023National basic fee paid 
24.11.2023Search fee paid 
24.11.2023Designation fee(s) paid 
24.11.2023Examination fee paid 
Examination procedure24.11.2023Examination requested  [2024/15]
Fees paidRenewal fee
30.05.2024Renewal fee patent year 03
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited inInternational search[XY]KR20190052697  (GAVISH GALILEE BIO APPL LTD [IL], et al);
 [A]WO2020070290  (ST ANNA KINDERKREBSFORSCHUNG [AT], et al);
 [A]KR20210012263  (UNIV NAT CHONNAM IND FOUND [KR]);
 [X]WO2021048850  (MIGAL GALILEE RES INSTITUTE LTD [IL]);
by applicantKR20070107721
 KR101521668B
 KR101528939B
 WO2015157252
 WO2016016473
 WO2016028896
 KR101636882B
 WO2017211900
 WO2018023025
 KR20180121904
 KR20180127344
 KR20180134347
 KR20200105840
 KR102157197B
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.